Načítá se...
Efficacy and Tolerability of High-dose Escitalopram in Posttraumatic Stress Disorder
Open label trials suggest that escitalopram (up to 20mg/d) is an effective treatment for some, but not all posttraumatic stress disorder (PTSD) patients. Higher doses of escitalopram effectively reduced major depression symptoms in patients who had not responded to regular doses. The current study e...
Uloženo v:
| Vydáno v: | J Clin Psychopharmacol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446897/ https://ncbi.nlm.nih.gov/pubmed/27977469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000626 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|